93% accuracy in new Alzheimer’s test, according to international study
February 23, 2022Research and Development
The Washington University School of Medicine in St Louis has developed a blood test for Alzheimer’s disease which has proved …
Extra blood test could help detect risk of death from heart attack
February 23, 2022Research and Development
Researchers say that an extra blood test on suspected heart-attack patients could determine if they are at high risk of …
FDA places gene therapy trial on hold
February 23, 2022Research and Development
Homology Medicines has shared that the FDA has placed its pheNIX gene therapy trial of HMI-102 in adults with phenylketonuria …
NICE recommends Albireo’s Bylvay (odevixibat) for all PFIC types
February 23, 2022Research and Development
NICE has issued guidance that recommends Bylvay (odevixibat) for the treatment of all types of progressive familial intrahepatic cholestasis (PFIC) …
FDA grants approval for expanded indication of heart failure sensor
February 22, 2022Manufacturing and Production
The FDA has granted approval for an expanded indication of Abbott’s CardioMEMS HF System, a small implantable sensor that can …
NovoBiome and Inserm begin collaboration into human intestinal physiology
February 22, 2022Manufacturing and Production
NovoBiome, a drug discovery company developing breakthrough Live Biotherapeutics Products, announced that it has signed a new collaboration with the …
UK to offer extra COVID-19 booster for over-75s and high risk in spring
February 22, 2022Manufacturing and Production
An additional booster dose will be offered to all adults over-75, as well as the most vulnerable over-12s, in the …
Apollo Therapeutics and King’s College London collaborate for translational biology and drug development
February 22, 2022Manufacturing and Production
Apollo Therapeutics has expanded its partnerships with world-leading UK research institutions, entering into a strategic collaboration with King’s College, London. …
CanSinoBIO’s Convidecia approved as heterologous COVID-19 booster in China
February 21, 2022Sales and Marketing
CanSino Biologics announced that its recombinant novel coronavirus vaccine has been approved by the Joint Prevention and Control Mechanism of …
FDA approval of first disease-modifying drug for treatment of rare lifelong anaemia
February 21, 2022Sales and Marketing
Agios Pharmaceuticals has announced the FDA approval of Pyrukynd (mitapivat), for the treatment of haemolytic anaemia in adults with pyruvate …
‘Historic’ results for breast cancer drug and promise for broader use
February 21, 2022Sales and Marketing
AstraZeneca has shared that its drug, Enhertu, has demonstrated meaningful survival improvements in patients with breast cancer, compared with physician’s …
FDA considers approving second COVID-19 booster jab
February 21, 2022Sales and Marketing
US health regulators are looking at authorising a potential fourth dose of a COVID-19 vaccine, as reported by the Wall …
Study shows antibiotics affect gut microbes of newborns
February 18, 2022Medical Communications
Researchers from the Universities of Edinburgh and Birmingham, with the Spaarne Hospital and University Medical Centre Utrecht, Netherlands, have conducted …
Pfizer and BioNTech Omicron vaccine delayed
February 18, 2022Medical Communications
The delivery of Pfizer and BioNTech SE’s vaccine, targeted specifically towards the Omicron COVID-19 variant has been delayed by several …
NHS bosses call for free COVID-19 tests and isolation to remain
February 18, 2022Medical Communications
NHS bosses have called for free COVID-19 testing to remain, in spite of speculation that this could be scrapped. Boris …
Trial paused for respiratory virus vaccine in pregnant women
February 18, 2022Medical Communications
GlaxoSmithKline (GSK) has hit pause on a Phase III clinical trial on safety grounds. The late-stage trial for GSK’s vaccine …
FDA accepts NDA for non-small cell lung cancer treatment
February 17, 2022Business Services
Mirati Therapeutics, a clinical-stage targeted oncology company has announced that the FDA has accepted the new drug application (NDA) for …
England to offer COVID-19 vaccine to five to 11-year-olds
February 17, 2022Business Services
Children aged between five and 11 in England will be offered a low-dose vaccine, according to the government. This move …
First Promising Innovative Medicine designation for self-administered treatment of rare disease
February 17, 2022Business Services
UCB has announced that zilucoplan, its developmental treatment for adults with generalized myasthenia gravis (gMG) has been granted Promising Innovative …
Virtual drug design platform to accelerate drug discovery
February 17, 2022Business Services
The Cambridge Crystallographic Data Centre (CCDC) announced a strategic partnership with Dassault Systemes to advance bioscience innovation with a cloud-based …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
